Resveratrol affects the cross talk between immune and colon cancer cells

Area of Science:

• Immunology
• Molecular Biology
• Nutraceuticals

Background:

• Resveratrol, a natural polyphenol from grapes, is recognized for therapeutic potential, particularly in cancer prevention.
• Understanding resveratrol's interaction with immune cells and cancer cells is crucial for elucidating its preventive mechanisms.

Purpose of the Study:

• To investigate resveratrol's effect on cytokine production during immune cell and colon carcinoma cell interactions.
• To explore resveratrol's role as a modulator of the immune dialog in the context of colon tumorigenesis.

Main Methods:

• Incubation of peripheral blood mononuclear cells (PBMCs) and human colon carcinoma cell lines with resveratrol.
• Quantification of cytokine production, including IL-6, IL-1ra, IL-10, and TNFα.
• Assessment of resveratrol's dose-dependent effects on cytokine release in co-culture systems.

Main Results:

• Resveratrol reduced IL-6, IL-1ra, and IL-10 production by non-stimulated PBMCs, while moderately increasing TNFα.
• Resveratrol did not alter cytokine production by the colon carcinoma cell lines alone.
• Co-incubation of immune and cancer cells with resveratrol resulted in a dose-dependent decrease in examined cytokine production.

Conclusions:

• Resveratrol influences immune cell cytokine profiles and alters the immune dialog with colon cancer cells.
• These findings suggest a novel mechanism involving immune modulation that may contribute to resveratrol's preventive effects against colon tumorigenesis.